Merck & Co

Pharmaceuticals
MRK
$ 93 1
Share price
$ 235 bn
Market Cap
$ 256 bn
Enterprise Value

Carbon footprint

3.9 Ton
GHG emissions per $ 1 mln investment
0.14x the weighted average for S&P 500
FY2020
How is this calculated?
-7.7%
YOY change in GHG emissions
Weaker than the -8.7% weighted average for S&P 500
FY2020 vs. previous year

Primary Climate Goal

-4.2%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Weaker than the -5.1% weighted average for S&P 500
FY2021
How is this calculated?

Merck & Co aims to reduce Scope 1 + 2 by 46% by 2030 from a base year 2019


1.5°C
Merck & Co's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

Secondary Climate Goal

-3%
Proj. YOY change in GHG emissions (Scope 3)
Weaker than the -6.3% weighted average for S&P 500
FY2021
How is this calculated?

Merck & Co aims to reduce Scope 3 by 30% by 2030 from a base year 2020


This target has not been verified as science based according to SBTi
Merck & Co's actual and proj. GHG emissions (Scope 3) (Kt of CO2e)

GHG emissions and Carbon intensity

Merck & Co's GHG emissions (market-based) (Kt of CO2e)
Merck & Co's Carbon intensity (Tons per 1 USDm)

Merck & Co's carbon footprint

Merck & Co reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 994 Kt (-83 /-7.7% y-o-y). Also positively, carbon intensity declined to 21 t (-2.3 /-10% y-o-y).

Merck & Co's Scope 3 emissions increased to 7,103 Kt (+138/+2% y-o-y). The growth rate declined vs. the previous periods (CAGR +4.4% since 4Q'18).

The company is committed to reducing Scope 1 + 2 by 46% by 2030 from a base year 2019, which translates into the estimated reduction of -41 Kt per annum over the period of FY2021 - FY2030. This science-based target is aligned with Paris Agreement to limit global warming to 1.5°C above pre-industrial levels.

Also, the company commits to reducing Scope 3 by 30% by 2030 from a base year 2020, which translates into the estimated reduction of -213 Kt per annum over the period of FY2021 - FY2030. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Merck & Co aims to achive carbon neutrality across its operations (Scope 1 + 2) in 2025. Companies normally become carbon neutral with the help of the acquisition of carbon offsets rather than absolute reductions in their own greenhouse emissions. Also, carbon neutrality does not include non-CO2 GHG emissions.

Company environmental metrics

Show more...